Alpha 2.0
Login Register
» Articles » PMID: 31531516

Interchangeability and Substitution of Biosimilars: is Health Technology Assessment (HTA) a Tool for Decision-making?

Overview
Journal Cad Saude Publica
Specialty Public Health
Date 2019 Sep 19
PMID 31531516
Citations 3
Authors
Bruna de Oliveira Ascef
Renan Goncalves Leonel da Silva
Haliton Alves de Oliveira Junior
Patricia Coelho de Soarez
Affiliations
Soon will be listed here.
Citing Articles

The advancement of artificial intelligence in biomedical research and health innovation: challenges and opportunities in emerging economies.

da Silva R Global Health. 2024; 20(1):44.

PMID: 38773458 PMC: 11107016. DOI: 10.1186/s12992-024-01049-5.

A Cross-Sectional Study of Quality of Life Among Brazilian Adults With Type 1 Diabetes Treated With Insulin Glargine: Findings and Implications.

Almeida P, Godman B, Nunes-Nogueira V, de Lemos L, de Assis Acurcio F, Guerra-Junior A Clin Diabetes. 2022; 40(3):312-326.

PMID: 35983417 PMC: 9331629. DOI: 10.2337/cd21-0068.

Health technology assessment of biosimilars worldwide: a scoping review.

de Oliveira Ascef B, de Freitas Lopes A, de Soarez P Health Res Policy Syst. 2020; 18(1):95.

PMID: 32843051 PMC: 7448328. DOI: 10.1186/s12961-020-00611-y.